Disease-A-Month
Volume 56, Issue 1 , Pages 6-31 , January 2010

Osteomyelitis

References 

  1. Browner BD. Skeletal trauma basic science, management, and reconstruction. In:  Browner BD editors. MDConsult. (ed 4). Philadelphia, PA: Saunders/Elsevier; 2009;
  2. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970;282:198–206
  3. Browner BD. Skeletal trauma basic science, management, and reconstruction. (ed 3). Philadelphia, PA: W. B. Saunders; 2003;
  4. Gillespie WJ. Epidemiology in bone and joint infection. Infect Dis Clin North Am. 1990;4:361–376
  5. Harrison's principles of internal medicine. McGraw-Hill Medical; 2008;http://www.accessmedicine.com/resourcetoc.aspx?resourceID=4
  6. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293:217–228
  7. Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot (Soft tissue and bone infection). Infect Dis Clin North Am. 1990;4:409–432
  8. Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: A progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24(suppl 1):S145–S161
  9. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients (Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy). Am J Med. 1987;83:653–660
  10. Nather A, Bee CS, Huak CY, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications. 2008;22:77–82
  11. Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998;6:484–488
  12. Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun. 1994;62:152–161
  13. Greenberg DP, Bayer AS, Cheung AL, et al. Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Infect Immun. 1989;57:1113–1118
  14. Littlewood-Evans AJ, Hattenberger MR, Luscher C, et al. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun. 1997;65:3438–3443
  15. Ziran BH. Osteomyelitis. J Trauma. 2007;62:S59–S60
  16. Ciampolini J, Harding KG. Pathophysiology of chronic bacterial osteomyelitis (Why do antibiotics fail so often?). Postgrad Med J. 2000;76:479–483
  17. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier/Churchill Livingstone; 2005;http://atoz.ebsco.com/link.asp?id=7227&sid=128189840&rid=400072&urlSource=AtoZ&lang=en
  18. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects (second of three parts). N Engl J Med. 1970;282:260–266
  19. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects (3. Osteomyelitis associated with vascular insufficiency). N Engl J Med. 1970;282:316–322
  20. Cierny G, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003;7–24
  21. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336:999–1007
  22. Sabir N, Rafi S, Hashmi I, et al. Lumbar osteomyelitis with Pseudomonas. J Pak Med Assoc. 2007;57:517–518
  23. Maman E, Bickels J, Ephros M, et al. Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis. 2007;45:1535–1540
  24. Stratov I, Korman TM, Johnson PD. Management of aspergillus osteomyelitis: Report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis. 2003;22:277–283
  25. Petitjean G, Fluckiger U, Scharen S, et al. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect. 2004;10:951–953
  26. Haller P, Bruderer T, Schaeren S, et al. Vertebral osteomyelitis caused by Actinobaculum schaalii: A difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis. 2007;26:667–670
  27. Mouzopoulos G, Stamatakos M, Tzurbakis M, et al. Lower extremity infections by Vibrio vulnificus. Chirurgia. 2008;103:201–203
  28. Vasoo S, Yeo SB, Lim PL, et al. Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: Case report and literature review. Int J Antimicrob Agents. 2008;31:184–185
  29. Amit A, Sudish K, Pople IK. Primary calvarial cryptococcal osteomyelitis in a patient with idiopathic lymphopenia. Acta Neurochir. 2008;150:713–714
  30. Oppenheimer M, Embil JM, Black B, et al. Blastomycosis of bones and joints. South Med J. 2007;100:570–578
  31. Yun HC, Branstetter JG, Murray CK. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma. 2008;64:S163–S168
  32. Phanzu DM, Bafende EA, Dunda BK, et al. Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg. 2006;75:311–314
  33. Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis. 2002;35:1390–1396
  34. Allman RM. Pressure ulcer prevalence, incidence, risk factors, and impact. Clin Geriatr Med. 1997;13:421–436
  35. Garibaldi RA, Brodine S, Matsumiya S. Infections among patients in nursing homes: Policies, prevalence, problems. N Engl J Med. 1981;305:731–735
  36. Darouiche RO, Landon GC, Klima M, et al. Osteomyelitis associated with pressure sores. Arch Intern Med. 1994;154:753–758
  37. Huang AB, Schweitzer ME, Hume E, et al. Osteomyelitis of the pelvis/hips in paralyzed patients: Accuracy and clinical utility of MRI. J Comput Assist Tomogr. 1998;22:437–443
  38. Thomas DR. The role of nutrition in prevention and healing of pressure ulcers. Clin Geriatr Med. 1997;13:497–511
  39. Grammatico L, Baron S, Rusch E, et al. Epidemiology of vertebral osteomyelitis (VO) in France: Analysis of hospital-discharge data 2002-2003. Epidemiol Infect. 2008;136:653–660
  40. Sapico FL, Montgomerie JZ. Pyogenic vertebral osteomyelitis: Report of nine cases and review of the literature. Rev Infect Dis. 1979;1:754–776
  41. Nolla JM, Ariza J, Gomez-Vaquero C, et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum. 2002;31:271–278
  42. Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: Analysis of 20 cases and review. Clin Infect Dis. 1995;20:320–328
  43. Kak V, Chandrasekar PH. Bone and joint infections in injection drug users. Infect Dis Clin North Am. 2002;16:681–695
  44. Pigrau C, Almirante B, Flores X, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: Incidence, risk factors, and outcome. Am J Med. 2005;118:1287
  45. Falagas ME, Bliziotis IA, Mavrogenis AF, et al. Spondylodiscitis after facet joint steroid injection: A case report and review of the literature. Scand J Infect Dis. 2006;38:295–299
  46. Cunha BA. Osteomyelitis in elderly patients. Clin Infect Dis. 2002;35:287–293
  47. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369–379
  48. Bass SN, Ailani RK, Shekar R, et al. Pyogenic vertebral osteomyelitis presenting as exudative pleural effusion: A series of five cases. Chest. 1998;114:642–647
  49. Abe E, Yan K, Okada K. Pyogenic vertebral osteomyelitis presenting as single spinal compression fracture: A case report and review of the literature. Spinal Cord. 2000;38:639–644
  50. Levin MH, Weinstein RA, Nathan C, et al. Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol. 1984;20:758–762
  51. Swisher LA, Roberts JR, Glynn MJ. Needle licker's osteomyelitis. Am J Emerg Med. 1994;12:343–346
  52. Suedkamp NP, Barbey N, Veuskens A, et al. The incidence of osteitis in open fractures: An analysis of 948 open fractures (a review of the Hannover experience). J Orthop Trauma. 1993;7:473–482
  53. Kindsfater K, Jonassen EA. Osteomyelitis in grade II and III open tibia fractures with late debridement. J Orthop Trauma. 1995;9:121–127
  54. Zalavras CG, Gupta N, Patzakis MJ, et al. Microbiology of osteomyelitis in patients infected with the human immunodeficiency virus. Clin Orthop Relat Res. 2005;439:97–100
  55. Weinstein MA, Eismont FJ. Infections of the spine in patients with human immunodeficiency virus. J Bone Joint Surg Am. 2005;87:604–609
  56. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis. 1982;41:11–14
  57. Klein MB, Chang J. Management of hand and upper-extremity infections in heart transplant recipients. Plast Reconstr Surg. 2000;106:598–601
  58. Cunha BA. Fever of unknown origin: Focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am. 2007;21:1137–1187
  59. Butalia S, Palda VA, Sargeant RJ, et al. Does this patient with diabetes have osteomyelitis of the lower extremity?. J Am Med Assoc. 2008;299:806–813
  60. Lipsky BA. Bone of contention: Diagnosing diabetic foot osteomyelitis. Clin Infect Dis. 2008;47:528–530
  61. Walenkamp GH. Chronic osteomyelitis. Acta Orthop Scand. 1997;68:497–506
  62. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers (Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline). J Am Med Assoc. 1991;266:1246–1251
  63. Senneville E, Melliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures. Clin Infect Dis. 2006;42:57–62
  64. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers (A clinical sign of underlying osteomyelitis in diabetic patients). J Am Med Assoc. 1995;273:721–723
  65. Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. J Am Med Assoc. 1978;239:2772–2775
  66. Zuluaga AF, Galvis W, Jaimes F, et al. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: An observational study. BMC Infect Dis. 2002;2:8
  67. Altay M, Arikan M, Yildiz Y, et al. Squamous cell carcinoma arising in chronic osteomyelitis in foot and ankle. Foot Ankle Int. 2004;25:805–809
  68. Ziets RJ, Evanski PM, Lusskin R, et al. Squamous cell carcinoma complicating chronic osteomyelitis in a toe: A case report and review of the literature. Foot Ankle. 1991;12:178–181
  69. Wu JS, Gorbachova T, Morrison WB, et al. Imaging-guided bone biopsy for osteomyelitis: Are there factors associated with positive or negative cultures?. AJR Am J Roentgenol. 2007;188:1529–1534
  70. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654–663
  71. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: Meta-analysis. Clin Infect Dis. 2008;47:519–527
  72. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol. 1992;158:9–18
  73. Gold RH, Hawkins RA, Katz RD. Bacterial osteomyelitis: Findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol. 1991;157:365–370
  74. Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: Current concepts. Infect Dis Clin North Am. 2006;20:789–825
  75. Termaat MF, Raijmakers PG, Scholten HJ, et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis. J Bone Joint Surg Am. 2005;87:2464–2471
  76. Ram PC, Martinez S, Korobkin M, et al. CT detection of intraosseous gas: A new sign of osteomyelitis. AJR Am J Roentgenol. 1981;137:721–723
  77. Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med. 1998;39:2145–2152
  78. Zhuang H, Duarte PS, Pourdehand M, et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000;25:281–284
  79. Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: Results of histologically confirmed cases. Eur J Nucl Med. 2000;27:524–528
  80. Keidar Z, Militianu D, Melamed E, et al. The diabetic foot: Initial experience with 18F-FDG PET/CT. J Nucl Med. 2005;46:444–449
  81. Love C, Tomas MB, Tronco GG, et al. FDG PET of infection and inflammation. Radiographics. 2005;25:1357–1368
  82. Senneville E, Lombart A, Beltrand E, et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: A retrospective cohort study. Diabetes Care. 2008;31:637–642
  83. Lipsky BA. Medical treatment of diabetic foot infections. Clin Infect Dis. 2004;39(suppl 2):S104–S114
  84. Priest DH, Peacock JE. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: Clinical features and therapeutic outcomes. South Med J. 2005;98:854–862
  85. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–360
  86. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161–189
  87. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52:1–77
  88. Rao N, Lipsky BA. Optimising antimicrobial therapy in diabetic foot infections. Drugs. 2007;67:195–214
  89. Blaser J, Vergeres P, Widmer AF, et al. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother. 1995;39:1134–1139
  90. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial (Foreign-Body Infection (FBI) Study Group). J Am Med Assoc. 1998;279:1537–1541
  91. Perlroth J, Kuo M, Tan J, et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: A systematic review of the literature. Arch Intern Med. 2008;168:805–819
  92. Peralta FG, Sanchez MB, Roiz MP, et al. Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam. Clin Infect Dis. 2003;37:1568–1572
  93. Vercillo M, Patzakis MJ, Holtom P, et al. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res. 2007;461:40–43
  94. Patel R, Piper KE, Rouse MS, et al. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother. 2000;44:3438–3440
  95. Lamp KC, Friedrich LV, Mendez-Vigo L, et al. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med. 2007;120:S13–S20
  96. Henke PK, Blackburn SA, Wainess RW, et al. Osteomyelitis of the foot and toe in adults is a surgical disease: Conservative management worsens lower extremity salvage. Ann Surg. 2005;241:885–892discussion 92-4
  97. Peck KR, Son DW, Song JH, et al. Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro. J Korean Med Sci. 2001;16:39–44
  98. de Lalla F, Pellizzer G, Strazzabosco M, et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother. 2001;45:1094–1098
  99. Patti JM. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine. 2004;22(suppl 1):S39–S43
  100. Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med. 2003;114:723–728
  101. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233:485–491
  102. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother. 2003;51:1261–1268
  103. Dombrowski JC, Winston LG. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect. 2008;57:110–115

PII: S0011-5029(09)00100-X

doi: 10.1016/j.disamonth.2009.07.001

Disease-A-Month
Volume 56, Issue 1 , Pages 6-31 , January 2010

Article Tools

* Image Usage & Resolution